Advertisement

Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry

Published:October 21, 2022DOI:https://doi.org/10.1016/j.dld.2022.09.020

      Abstract

      Background

      Direct comparisons of childhood- and adulthood-onset eosinophilic esophagitis (EoE) are scarce.

      Aim

      To compare disease characteristics, endoscopic and histological features, allergic concomitances and therapeutic choices across ages.

      Methods

      Cross-sectional analysis of the EoE CONNECT registry.

      Results

      The adulthood-onset cohort (those diagnosed at ≥18y) comprised 1044 patients and the childhood‐onset cohort (patients diagnosed at <18 y), 254. Vomiting, nausea, chest and abdominal pain, weight loss, slow eating and food aversion were significantly more frequent in children; dysphagia, food bolus impaction and heartburn predominated in adults. A family history of EoE was present in 16% of pediatric and 8.2% of adult patients (p<0.001). Concomitant atopic diseases did not vary across ages. Median±IQR diagnostic delay (years) from symptom onset was higher in adults (2.7 ± 6.1) than in children (1 ± 2.1; p<0.001). Esophageal strictures and rings predominated in adults (p<0.001), who underwent esophageal dilation more commonly (p = 0.011). Inflammatory EoE phenotypes were more common in children (p = 0.001), who also presented higher eosinophil counts in biopsies (p = 0.015) and EREFS scores (p = 0.017). Despite PPI predominating as initial therapy in all cohorts, dietary therapy and swallowed topical corticosteroids were more frequently prescribed in children (p<0.001).

      Conclusions

      Childhood‐onset EoE has differential characteristics compared with adulthood-onset, but similar response to treatment.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Digestive and Liver Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Arias Á.
        • Lucendo A.J.
        Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
        Expert Rev Gastroenterol Hepatol. 2019; 13: 99-117
        • Arias Á.
        • Lucendo A.J.
        Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: a 12-year population-based study.
        Dig Liver Dis. 2019; 51: 55-62
        • Robson J.
        • O'Gorman M.
        • McClain A.
        • et al.
        Incidence and prevalence of pediatric eosinophilic esophagitis in utah based on a 5-year population-based study.
        Clin Gastroenterol Hepatol. 2019; 17 (e1): 107-114
        • Cianferoni A.
        • Jensen E.
        • Davis C.M.
        The role of the environment in eosinophilic esophagitis.
        J Allergy Clin Immunol Pract. 2021; 9: 3268-3274
        • Jensen E.T.
        • Kuhl J.T.
        • Martin L.J.
        • et al.
        Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis.
        J Allergy Clin Immunol. 2018; 141 (e5): 632-637
        • Laserna-Mendieta E.J.
        • FitzGerald J.A.
        • Arias-Gonzalez L.
        • et al.
        Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies.
        Sci Rep. 2021; 11: 7113
        • Arias Á.
        • Lucendo A.J.
        Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians.
        Expert Rev Gastroenterol Hepatol. 2020; 14: 1069-1082
        • Lucendo A.J.
        • Sanchez-Cazalilla M.
        Adult versus pediatric eosinophilic esophagitis: important differences and similarities for the clinician to understand.
        Expert Rev Clin Immunol. 2012; 8: 733-745
        • Straumann A.
        • Aceves S.S.
        • Blanchard C.
        • et al.
        Pediatric and adult eosinophilic esophagitis: similarities and differences.
        Allergy. 2012; 67: 477-490
        • Visaggi P.
        • Savarino E.
        • Sciume G.
        • et al.
        Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults.
        Ther Adv Gastroenterol. 2021; 141756284820980860
        • Chehade M.
        • Jones S.M.
        • Pesek R.D.
        • et al.
        Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research.
        J Allergy Clin Immunol Pract. 2018; 6 (e5): 1534-1544
        • Anderson J.
        • Moonie S.
        • Hogan M.B.
        • et al.
        Eosinophilic esophagitis: comorbidities and atopic disease in Nevada.
        Dis Esophagus. 2020; 33: doz105
        • Ridolo E.
        • Martignago I.
        • Pellicelli I.
        • et al.
        Assessing the risk factors for refractory eosinophilic esophagitis in children and adults.
        Gastroenterol Res Pract. 2019; 20191654543
        • Lingblom C.
        • Käppi T.
        • Bergquist H.
        • et al.
        Differences in eosinophil molecular profiles between children and adults with eosinophilic esophagitis.
        Allergy. 2017; 72: 1406-1414
        • Lucendo A.J.
        • Molina-Infante J.
        • Arias A.
        • et al.
        Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.
        United Eur Gastroenterol J. 2017; 5: 335-358
        • Dellon E.S.
        • Liacouras C.A.
        • Molina-Infante J.
        • et al.
        Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference.
        Gastroenterology. 2018; 155: 1022-1033
        • Noel R.J.
        • Putnam P.E.
        • Rothenberg M.E.
        Eosinophilic esophagitis.
        N Engl J Med. 2004; 351: 940-941
        • Ahuja N.
        • Weedon J.
        • Schwarz S.M.
        • et al.
        Applying the eosinophilic esophagitis endoscopic reference scores (EREFS) to different aged children.
        J Pediatr Gastroenterol Nutr. 2020; 71: 328-332
        • Hoofien A.
        • Dias J.A.
        • Malamisura M.
        • et al.
        Pediatric eosinophilic esophagitis: results of the european retrospective pediatric eosinophilic esophagitis registry (RetroPEER).
        J Pediatr Gastroenterol Nutr. 2019; 68: 552-558
        • Ketchem C.J.
        • Thakkar K.P.
        • Xue A.
        • et al.
        Older patients with eosinophilic esophagitis have high treatment response to topical steroids.
        Dig Liver Dis. 2021; S1590-8658 (00809–4)
        • Lucendo A.
        • Santander C.
        • Savarino E.
        • et al.
        EoE CONNECT, the European registry of clinical, environmental and genetic determinants in eosinophilic esophagitis: rationale, design and study protocol of a large-scale epidemiological study in Europe.
        Ther Adv Gastroenterol. 2022; 1517562848221074204
        • Hirano I.
        • Moy N.
        • Heckman M.G.
        • et al.
        Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.
        Gut. 2013; 62: 489-495
        • Lucendo A.J.
        • Arias A.
        • Molina-Infante J.
        • et al.
        The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy.
        Expert Rev Gastroenterol Hepatol. 2017; 11: 1135-1149
        • Lipka S.
        • Kumar A.
        • Richter J.E.
        Impact of diagnostic delay and other risk factors on eosinophilic esophagitis phenotype and esophageal diameter.
        J Clin Gastroenterol. 2016; 50: 134-140
        • Thaker A.I.
        • Melo D.M.
        • Samandi L.Z.
        • et al.
        Esophageal fibrosis in eosinophilic gastrointestinal diseases.
        J Pediatr Gastroenterol Nutr. 2021; 72: 392-397
        • Straumann A.
        • Conus S.
        • Degen L.
        • et al.
        Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.
        Gastroenterology. 2010; 139 (1537.e1): 1526-1537
        • Rank M.A.
        • Sharaf R.N.
        • Furuta G.T.
        • et al.
        Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters.
        Ann Allergy Asthma Immunol. 2020; 124 (e17): 424-440
        • Shoda T.
        • Wen T.
        • Aceves S.S.
        • et al.
        Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.
        Lancet Gastroenterol Hepatol. 2018; 3: 477-488
        • Oliva S.
        • Dias J.A.
        • Rea F.
        • et al.
        Characterization of eosinophilic esophagitis from the european pediatric eosinophilic esophagitis registry (pEEr) of ESPGHAN.
        J Pediatr Gastroenterol Nutr. 2022; 75: 325-333
        • Chang N.C.
        • Thakkar K.P.
        • Ketchem C.J.
        • et al.
        A gap in care leads to progression of fibrosis in eosinophilic esophagitis patients.
        Clin Gastroenterol Hepatol. 2021; S1542-3565 (01141–1)
        • Schoepfer A.M.
        • Safroneeva E.
        • Bussmann C.
        • et al.
        Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.
        Gastroenterology. 2013; 145 (e1–2): 1230-1236
        • Dellon E.S.
        • Kim H.P.
        • Sperry S.L.W.
        • et al.
        A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.
        Gastrointest Endosc. 2014; 79 (e4): 577-585
        • Liacouras C.A.
        Clinical presentation and treatment of pediatric patients with eosinophilic esophagitis.
        Gastroenterol Hepatol. 2011; 7: 264-267
        • Dellon E.S.
        • Jensen E.T.
        • Martin C.F.
        • et al.
        Prevalence of eosinophilic esophagitis in the United States.
        Clin Gastroenterol Hepatol. 2014; 12 (e1): 589-596
        • Molina-Infante J.
        • Gonzalez-Cordero P.L.
        • Ferreira-Nossa H.C.
        • et al.
        Rising incidence and prevalence of adult eosinophilic esophagitis in midwestern Spain (2007-2016).
        United Eur Gastroenterol J. 2018; 6: 29-37
        • Hirano I.
        • Collins M.H.
        • Assouline-Dayan Y.
        • et al.
        RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis.
        Gastroenterology. 2019; 156 (e10): 592-603
        • Hirano I.
        • Collins M.H.
        • Katzka D.A.
        • et al.
        Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: results from a Phase 3 Trial.
        Clin Gastroenterol Hepatol. 2022; 20: 525-534
        • Lucendo A.J.
        • Miehlke S.
        • Schlag C.
        • et al.
        Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial.
        Gastroenterology. 2019; 157 (e15): 74-86
        • Alexander E.S.
        • Martin L.J.
        • Collins M.H.
        • et al.
        Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis.
        J Allergy Clin Immunol. 2014; 134 (e1): 1084-1092
        • Allen-Brady K.
        • Firszt R.
        • Fang J.C.
        • et al.
        Population-based familial aggregation of eosinophilic esophagitis suggests a genetic contribution.
        J Allergy Clin Immunol. 2017; 140: 1138-1143
        • Collins M.H.
        • Blanchard C.
        • Abonia J.P.
        • et al.
        Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases.
        Clin Gastroenterol Hepatol. 2008; 6: 621-629
        • Vernon N.
        • Shah S.
        • Lehman E.
        • et al.
        Comparison of atopic features between children and adults with eosinophilic esophagitis.
        Allergy Asthma Proc. 2014; 35: 409-414
        • Hill D.A.
        • Grundmeier R.W.
        • Ramos M.
        • et al.
        Eosinophilic esophagitis is a late manifestation of the allergic march.
        J Allergy Clin Immunol Pract. 2018; 6: 1528-1533
        • Tourlamain G.
        • Garcia-Puig R.
        • Gutiérrez-Junquera C.
        • et al.
        Differences in management of eosinophilic esophagitis in Europe: an assessment of current practice.
        J Pediatr Gastroenterol Nutr. Jul 2020; 71: 83-90
        • Miehlke S.
        • von Arnim U
        • Schlag C.
        • et al.
        Clinical management of eosinophilic esophagitis - a nationwide survey among gastroenterologists in Germany.
        Z Gastroenterol. 2019; 57: 745-752
        • Chang J.W.
        • Saini S.D.
        • Mellinger J.L.
        • et al.
        Management of eosinophilic esophagitis is often discordant with guidelines and not patient-centered: results of a survey of gastroenterologists.
        Dis Esophagus. 2019; 32: doy133
        • Hannan N.
        • Steel A.
        • McMillan S.S.
        • et al.
        Health service use and treatment choices for pediatric eosinophilic esophagitis: findings from a cross-sectional survey of australian carers.
        Front Pediatr. 2020; 8: 147
        • Laserna-Mendieta E.J.
        • Casabona S.
        • Savarino E.
        • et al.
        Efficacy of therapy for eosinophilic esophagitis in real-world practice.
        Clin Gastroenterol Hepatol. 2020; 18 (e4): 2903-2911
        • Navarro P.
        • Laserna-Mendieta E.J.
        • Guagnozzi D.
        • et al.
        Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
        Dig Liver Dis. 2021; 53: 1479-1485
        • Runge T.M.
        • Eluri S.
        • Woosley J.T.
        • et al.
        Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
        Dis Esophagus. 2017; 30: 1-7
        • Schupack D.A.
        • Ravi K.
        • Geno D.M.
        • et al.
        Effect of maintenance therapy for eosinophilic esophagitis on need for recurrent dilation.
        Dig Dis Sci. 2021; 66: 503-510
        • Lucendo A.J.
        • Arias T.
        • Molina-Infante J.
        • et al.
        Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice.
        Dig Liver Dis. 2013; 45: 562-568
        • Navarro P.
        • Laserna-Mendieta E.J.
        • Casabona S.
        • et al.
        Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry.
        United European Gastroenterol J. 2022; 10: 507-517
        • Jia J.
        • Chan E.S.
        • Avinashi V.
        • et al.
        Aiming for a shorter time to diagnosis: pediatric eosinophilic esophagitis in British Columbia.
        Allergy Asthma Clin Immunol. 2020; 16: 88